Google DeepMind Unveils AlphaGenome 2 to Predict DNA Variant Effects on Human Cells

Google DeepMind announced AlphaGenome 2, an upgraded AI model that predicts how DNA sequences and variations impact specific human cell types, aiming to uncover disease-causing cellular factors. The model's capabilities and validation details remain unclear, but it represents a notable advance in genomic AI. This could accelerate disease research and drug discovery, though clinical impact is unproven.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works